Jacky Luiten

Introduction and outline | 13 1 20. Jorgensen KJ, Gotzsche PC, Kalager M, Zahl PH. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. Ann Intern Med. 2017;166(5):313‐323. 21. Honig EL, Mullen LA, Amir T, Alvin MD, Jones MK, Ambinder EB, et al. Factors Impacting False Positive Recall in Screening Mammography. Acad Radiol. 2019;26(11):1505‐1512. 22. Rougraff BT, Aboulafia A, Biermann JS, Healey J. Biopsy of soft tissue masses: evidence‐based medicine for the musculoskeletal tumor society. Clin Orthop Relat Res. 2009;467(11):2783‐2791. 23. van Breest Smallenburg V, Nederend J, Voogd AC, Coebergh JW, van Beek M, Jansen FH, et al. Trends in breast biopsies for abnormalities detected at screening mammography: a population‐based study in the Netherlands. Br J Cancer. 2 013;109(1):242‐248. 24. St‐Armant M, Weerakkody Y. High risk breas t lesion: Radiopaedia; 2017 . Available from: https://radiopaedia.org/articles/high ‐risk‐breast‐ lesion?lang=us. 25. IKNL. Netherlands Cancer Registry Ava ilable from: https://www.iknl.nl/en/ncr. 26. PALGA Foundation. Available from : https://w ww.palga.nl/en/about‐stichti ng‐palga/stichting‐ palga.html.